{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:17:32Z","timestamp":1786987052579,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.clml.2020.11.011","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T10:34:03Z","timestamp":1605868443000},"page":"e402-e409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Burden in Caregivers of Multiple Myeloma Patients Undergoing Outpatient Autologous Stem-Cell Transplantation Compared to Inpatient Transplantation"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3987-419X","authenticated-orcid":false,"given":"Massimo","family":"Martino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Pitino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tripepi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Paviglianiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letteria","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppa","family":"Cusumano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale Fabio","family":"Provenzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetana","family":"Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Meliambro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Porcino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Gangemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"D\u2019Arrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrezia","family":"Imbalzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Console","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.11.011_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-018-3546-8","article-title":"Navigating the treatment landscape in multiple myeloma: which combinations to use and when?","volume":"98","author":"Goldschmidt","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2020.11.011_bib2","doi-asserted-by":"crossref","first-page":"101155","DOI":"10.1016\/j.beha.2020.101155","article-title":"Multiple myeloma: current advances and future directions","volume":"33","author":"Ola Landgren","year":"2020","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.clml.2020.11.011_bib3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa1402888","article-title":"Autologous transplantation and maintenance therapy in multiple myeloma","volume":"371","author":"Palumbo","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2020.11.011_bib4","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S1470-2045(15)00389-7","article-title":"Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial","volume":"16","author":"Gay","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2020.11.011_bib5","doi-asserted-by":"crossref","first-page":"e456","DOI":"10.1016\/S2352-3026(20)30099-5","volume":"7","author":"Cavo","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.clml.2020.11.011_bib6","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJMoa1611750","article-title":"Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma","volume":"376","author":"Attal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2020.11.011_bib7","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current Use of and Trends in Hematopoietic Cell Transplantation in the United States","volume":"26","author":"D\u2019Souza","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2020.11.011_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-020-0826-4","article-title":"The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T\u2019s come into focus","author":"Passweg","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2020.11.011_bib9","first-page":"1192","article-title":"Feasibility of a mixed inpatient\u2013outpatient model of peripheral blood stem cell transplantation for multiple myeloma","volume":"87","author":"Morabito","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2020.11.011_bib10","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4065\/83.10.1131","article-title":"Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative","volume":"83","author":"Gertz","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clml.2020.11.011_bib11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/10428190802535098","article-title":"Early discharge after high-dose melphalan and peripheral blood stem cell reinfusion in patients with hematological and non-hematological disease","volume":"50","author":"Anastasia","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.11.011_bib12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/bmt.2011.126","article-title":"Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs","volume":"47","author":"Faucher","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2020.11.011_bib13","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bbmt.2014.03.027","article-title":"Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective study","volume":"20","author":"Martino","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2020.11.011_bib14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3109\/10428194.2014.931952","article-title":"A\u00a0home-care, early discharge model after autografting in multiple myeloma: results of a three-arm prospective, non-randomized study","volume":"56","author":"Martino","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.11.011_bib15","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/ejh.12970","article-title":"Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma","volume":"99","author":"Shah","year":"2017","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2020.11.011_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12885-017-3137-4","article-title":"High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting","volume":"17","author":"Lisenko","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clml.2020.11.011_bib17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nrclinonc.2010.104","article-title":"200 mg\/m2 melphalan\u2014the gold standard for multiple myeloma","volume":"7","author":"Giralt","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.clml.2020.11.011_bib18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1517\/13543784.2013.788643","article-title":"Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma","volume":"22","author":"Martino","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.clml.2020.11.011_bib19","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/bmt.2016.79","article-title":"Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma","volume":"51","author":"Martino","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2020.11.011_bib20","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1186\/s12885-018-5054-6","article-title":"Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis","volume":"18","author":"Owattanapanich","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clml.2020.11.011_bib21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbmt.2012.12.006","article-title":"Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma","volume":"19","author":"Holbro","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2020.11.011_bib22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.clml.2017.05.018","article-title":"Autologous stem cell transplantation in patients with multiple myeloma: an activity-based costing analysis, comparing a total inpatient model versus an early discharge model","volume":"17","author":"Martino","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2020.11.011_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.bmt.1702534","article-title":"A\u00a0comparison of inpatient and outpatient ASCT","volume":"26","author":"Summers","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2020.11.011_bib24","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.bbmt.2017.09.021","article-title":"A\u00a0comparative assessment of quality of life in patients with multiple myeloma undergoing autologous stem cell transplantation through an outpatient and inpatient model","volume":"24","author":"Martino","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2020.11.011_bib25","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1097\/NCC.0b013e31820a592d","article-title":"Informal caregivers of hematopoietic cell transplant patients: a review and recommendations for interventions and research","volume":"34","author":"Gemmill","year":"2011","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.clml.2020.11.011_bib26","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/pon.1962","article-title":"The experience of caregivers of hematological cancer patients undergoing a hematopoietic stem cell transplant: a comprehensive literature review","volume":"20","author":"Beattie","year":"2011","journal-title":"Psychooncology"},{"key":"10.1016\/j.clml.2020.11.011_bib27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.bmt.1705525","article-title":"Autologous hematopoietic stem cell transplants that utilize total body irradiation can safely be carried out entirely on an outpatient basis","volume":"38","author":"Stiff","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2020.11.011_bib28","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2020.11.011_bib29","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0277-9536(98)00426-2","article-title":"Measuring both negative and positive reactions to giving care to cancer patients: psychometric qualities of the Caregiver Reaction Assessment (CRA)","volume":"48","author":"Nijboer","year":"1999","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.clml.2020.11.011_bib30","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic Cell Transplantation (HCT)-Specific Comorbidity Index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.11.011_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1188\/05.ONF.57-67","article-title":"Quality of life, quality of care, and patient satisfaction: perceptions of patients undergoing outpatient autologous stem cell transplantation","volume":"32","author":"Schulmeister","year":"2005","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.clml.2020.11.011_bib32","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/bmt.2012.208","article-title":"Validating the positive impact of in-hospital lay care-partner support on patient survival in allogeneic BMT: a prospective study","volume":"48","author":"Foster","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2020.11.011_bib33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1523-5394.2000.83005.x","article-title":"Caregiver responses and needs. An ambulatory bone marrow transplant model","volume":"8","author":"Grimm","year":"2000","journal-title":"Cancer Pract"},{"key":"10.1016\/j.clml.2020.11.011_bib34","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/sj.bmt.1701191","article-title":"Reduced charges and costs associated with outpatient autologous stem cell transplantation","volume":"21","author":"Meisenberg","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2020.11.011_bib35","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1200\/JCO.2006.06.4238","article-title":"Case\u2013control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies","volume":"24","author":"Fern\u00e1ndez-Avil\u00e9s","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.11.011_bib36","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/sj.bmt.1703676","article-title":"Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program","volume":"30","author":"Frey","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2020.11.011_bib37","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.2016.16786","article-title":"Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial","volume":"316","author":"El-Jawahri","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.clml.2020.11.011_bib38","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/cncr.29149","article-title":"Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation","volume":"121","author":"El-Jawahri","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2020.11.011_bib39","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1017\/S1041610213001178","article-title":"Validity, reliability, and feasibility of the German version of the Caregiver Reaction Assessment scale (G-CRA): a validation study","volume":"25","author":"Stephan","year":"2013","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.clml.2020.11.011_bib40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1200\/EDBK_176093","article-title":"mHealth: mobile technologies to virtually bring the patient into an oncology practice","volume":"37","author":"Pennell","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.clml.2020.11.011_bib41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1017\/S1478951516000572","article-title":"Increasing access to care for young adults with cancer: results of a quality-improvement project using a novel telemedicine approach to supportive group psychotherapy","volume":"15","author":"Melton","year":"2017","journal-title":"Palliat Support Care"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020306352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020306352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T02:36:03Z","timestamp":1730514963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020306352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2152265020306352"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.11.011","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Burden in Caregivers of Multiple Myeloma Patients Undergoing Outpatient Autologous Stem-Cell Transplantation Compared to Inpatient Transplantation","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}